TABLE of SURGICAL PROCEDURES (Updated As of 1 Feb 2021)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Szanowni Państwo, Ladies and Gentlemen
Szanowni Państwo, Oddajemy w Państwa ręce piąte wydanie Katalogu Szpitali Prywatnych. Lecznice, skupione w Ogólnopolskim Stowarzyszeniu Szpitali Prywatnych, dysponują ilością niemal 10 000 łóżek, zatrudniają ponad 35 000 personelu i prawie 60 000 osób współpracujących. Zarządy naszych placówek wciąż podkreślają swą misję publiczną, jaką pełnią szpitale prywatne, świadcząc leczenie w ramach Narodowego Funduszu Zdrowia (96% wykonanych zabiegów). W tym roku Ogólnopolskie Stowarzyszenie Szpitali Prywatnych weszło w 16 rok działalności. Katalog nasz pokazuje, ile ciężkiej pracy wykonali polscy pracodawcy, tworząc tak piękne i przyjazne dla pacjenta ośrodki, które za sprawą Narodowego Funduszu Zdrowia świadczą wysokospecjalistyczną pomoc dla każdego polskiego obywatela. Uzupełnieniem katalogu od kilku lat stał się wydawany cyklicznie zeszyt statystyczny opisujący w sposób uporządkowany funkcjonowanie i toczenie ekonomiczne sektora szpitali prywatnych. Andrzej Sokołowski Prezes Zarządu Ogólnopolskiego Stowarzyszenia Szpitali Prywatnych Ladies and Gentlemen, We are pleased to present to you the fifth edition of the Catalogue of Private Hospitals. The entities affiliated in the Polish Association of Private Hospitals have almost 10.000 hospital beds, employ over 35.000 medical staff and almost 60.000 other personnel. Our hospitals’ directors keep underlining that the private medical centres also fulfil a public healthcare mission, delivering healthcare services within the National Health Fund (96% of all their procedures). UNION EUROPEENNE HOSPITALISATION -
Septoplasty, Rhinoplasty, Septorhinoplasty, Turbinoplasty Or
Septoplasty, Rhinoplasty, Septorhinoplasty, 4 Turbinoplasty or Turbinectomy CPAP • If you have obstructive sleep apnea and use CPAP, please speak with your surgeon about how to use it after surgery. Follow-up • Your follow-up visit with the surgeon is about 1 to 2 weeks after Septoplasty, Rhinoplasty, Septorhinoplasty, surgery. You will need to call for an appointment. Turbinoplasty or Turbinectomy • During this visit any nasal packing or stents will be removed. Who can I call if I have questions? For a healthy recovery after surgery, please follow these instructions. • If you have any questions, please contact your surgeon’s office. Septoplasty is a repair of the nasal septum. You may have • For urgent questions after hours, please call the Otolaryngologist some packing up your nose or splints which stay in for – Head & Neck (ENT) surgeon on call at 905-521-5030. 7 to 14 days. They will be removed at your follow up visit. When do I need medical help? Rhinoplasty is a repair of the nasal bones. You will have a small splint or plaster on your nose. • If you have a fever 38.5°C (101.3°F) or higher. • If you have pain not relieved by medication. Septorhinoplasty is a repair of the nasal septum and the nasal bone. You will have a small splint or plaster cast on • If you have a hot or inflamed nose, or pus draining from your nose, your nose. or an odour from your nose. • If you have an increase in bleeding from your nose or on Turbinoplasty surgery reduces the size of the turbinates in your dressing. -
Burns, Surgical Treatment
Philippine College of Surgeons Dear PCS Fellows, We at the PCS Committee on HMO, RVS, & PHIC & The PCS Board of Regents are pleased to announce the Adoption of PAHMOC of our new & revised RVS. We are currently under negotiations with them with regard to the multiplier to be used to arrive at our final professional Fees. Rest assured that we will have a graduated & staggered increase of PF thru the years from what we are currently receiving due to the proposed yearly increments in the multiplier. To those Fellows who haven’t signed the USA (Universal Service Agreement found here in our PCS website) please be reminded to sign and submit to the PCS Secretariat, as only those who did and are in good standing (updated annual dues) will be eligible to avail of the benefits of the new RVS scale. Indeed, we are hoping & looking forward to a merrier 2020 Christmas for our Fellows. Yours truly, FERNANDO L. LOPEZ, MD, FPCS Chairman Noted by: JOSELITO M. MENDOZA, MD, FPCS Regent-in-Charge JOSE ANTONIO M. SALUD, MD, FPCS President For many years now the PCS Committee on HMO & RUV has been compiling, with the assistance of the different surgical subspecialties, a new updated list of RUV for each procedure to replace the existing manual of 2009. This new version not only has a more complete listing of cases but also includes the newly developed procedures particularly for all types of minimally invasive operations. Sometime last year, the Department of Health released Circular 2019-0558 on the Public Access to the Price Information by all Health Providers as required by Section 28.16 of the IRR of the Universal Health Care Act. -
High Number of Endometrial Polyps Is a Strong Predictor of Recurrence: findings of a Prospective Cohort Study in Reproductive-Age Women
ORIGINAL ARTICLE: GYNECOLOGY AND MENOPAUSE High number of endometrial polyps is a strong predictor of recurrence: findings of a prospective cohort study in reproductive-age women Fang Gu, M.D.,a Huanxiao Zhang, M.D.,b Simin Ruan, M.D.,c Jiamin Li, M.D.,d Xinyan Liu, M.D.,a Yanwen Xu, M.D.,a,e and Canquan Zhou, M.D.a,e a Center for Reproductive Medicine, Department of Obstetrics and Gynecology, b Division of Gynecology, Department of Obstetrics and Gynecology, and c Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, First Affiliated Hospital of Sun Yat-sen University; d Department of Obstetrics and Gynecology, Second Affiliated Hospital of Guangzhou Medical College; and e Key Laboratory of Reproductive Medicine of Guangdong Province, Guangzhou, People's Republic of China Objective: To compare the incidence of recurrence between a cohort with a high number (R6) of endometrial polyps (EPs) and a single- EP cohort among reproductive-age patients after polypectomy. Design: Prospective observational cohort study. Setting: Single university center. Patient(s): Premenopausal women who underwent hysteroscopic endometrial polypectomy were recruited. Intervention(s): Patients underwent a transvaginal ultrasound scan every 3 months after polypectomy to detect EP recurrence. Kaplan- Meier and Cox regression models were used to compare the risk of recurrence between the two cohorts and analyze the potential risk factors for EP recurrence. Main Outcome Measure(s): EP recurrence rate. Result(s): The study enrolled 101 cases with a high number of EP and 81 cases with a single EP. All baseline parameters were similar except that the high number of EP cohort had a slightly lower mean age than the single EP cohort (33.5 [range 30.0–39.0] vs. -
Rhinoplasty and Septorhinoplasty These Services May Or May Not Be Covered by Your Healthpartners Plan
Rhinoplasty and septorhinoplasty These services may or may not be covered by your HealthPartners plan. Please see your plan documents for your specific coverage information. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage. Administrative Process Prior authorization is not required for: • Septoplasty • Surgical repair of vestibular stenosis • Rhinoplasty, when it is done to repair a nasal deformity caused by cleft lip/ cleft palate Prior authorization is required for: • Rhinoplasty for any indication other than cleft lip/ cleft palate • Septorhinoplasty Coverage Rhinoplasty is not covered for cosmetic reasons to improve the appearance of the member, but may be covered subject to the criteria listed below and per your plan documents. The service and all related charges for cosmetic services are member responsibility. Indications that are covered 1. Primary rhinoplasty (30400, 30410) may be considered medically necessary when all of the following are met: A. There is anatomical displacement of the nasal bone(s), septum, or other structural abnormality resulting in mechanical nasal airway obstruction, and B. Documentation shows that the obstructive symptoms have not responded to at least 3 months of conservative medical management, including but not limited to nasal steroids or immunotherapy, and C. Photos clearly document the structural abnormality as the primary cause of the nasal airway obstruction, and D. Documentation includes a physician statement regarding why a septoplasty would not resolve the airway obstruction. 2. Secondary rhinoplasty (30430, 30435, 30450) may be considered medically necessary when: A. The secondary rhinoplasty is needed to treat a complication/defect that was caused by a previous surgery (when the previous surgery was not cosmetic), and B. -
2021 – the Following CPT Codes Are Approved for Billing Through Women’S Way
WHAT’S COVERED – 2021 Women’s Way CPT Code Medicare Part B Rate List Effective January 1, 2021 For questions, call the Women’s Way State Office 800-280-5512 or 701-328-2389 • CPT codes that are specifically not covered are 77061, 77062 and 87623 • Reimbursement for treatment services is not allowed. (See note on page 8). • CPT code 99201 has been removed from What’s Covered List • New CPT codes are in bold font. 2021 – The following CPT codes are approved for billing through Women’s Way. Description of Services CPT $ Rate Office Visits New patient; medically appropriate history/exam; straightforward decision making; 15-29 minutes 99202 72.19 New patient; medically appropriate history/exam; low level decision making; 30-44 minutes 99203 110.77 New patient; medically appropriate history/exam; moderate level decision making; 45-59 minutes 99204 165.36 New patient; medically appropriate history/exam; high level decision making; 60-74 minutes. 99205 218.21 Established patient; evaluation and management, may not require presence of physician; 99211 22.83 presenting problems are minimal Established patient; medically appropriate history/exam, straightforward decision making; 10-19 99212 55.88 minutes Established patient; medically appropriate history/exam, low level decision making; 20-29 minutes 99213 90.48 Established patient; medically appropriate history/exam, moderate level decision making; 30-39 99214 128.42 minutes Established patient; comprehensive history exam, high complex decision making; 40-54 minutes 99215 128.42 Initial comprehensive -
New Patient Paperwork: Women
The Texas Center for Reproductive Acupuncture ______________________________________________________________ Patient Intake Form: Women __________________________________________________________________________________________________________________________________________________________________________________________________________________ Important: The information on this form will help your acupuncturist to give you the best and most comprehensive care possible. It is important for you to complete this document as thoroughly as possible. Even though some of the questions may seem completely unrelated to your condition, they may play a contributing, or underlying role in diagnosis and treatment of your problem. __________________________________________________________________________________________________________________________________________________________________________________________________________________ General Patient Information (All of the information provided is strictly confidential – see permission to share medical information section) Last Name: _____________________________ First Name: _______________________________ Middle Initial: _______ Age: ______ Primary Telephone Number: ____________________________________ Alternative Phone # ______________________________________ E-Mail: ____________________________________ Date of Birth ____ / _____ / _____ Today’s Date ___/___/_____ Number of Name of your Menstrual Cycle Pregnancies Age menstruation began: _______ Cesarean Births Ob/Gyn: __________________________________________ -
Journal 2017
Journal of ENT masterclass ISSN 2047-959X Journal of ENT MASTERCLASS® Year Book 2017 Volume 10 Number 1 YEAR BOOK 2017 VOLUME 10 NUMBER 1 JOURNAL OF ENT MASTERCLASS® Volume 10 Issue 1 December 2017 Contents Free Courses for Trainees, Consultants, SAS grades, GPs & Nurses Welcome Message 3 CALENDER OF FREE RESOURCES 2018-19 Hesham Saleh Increased seats for specialist registrars & exam candidates ENT aspects of cystic fibrosis management 4 Gary J Connett ® 15th Annual International ENT Masterclass Paediatric swallowing disorders 8 Venue: Doncaster Royal Infirmary, 25-27th January 2019 Hayley Herbert and Shyan Vijayasekaran Special viva sessions for exam candidates Paediatric tongue-tie 14 Steven Frampton, Ciba Paul, Andrea Burgess and Hasnaa Ismail-Koch rd ® 3 ENT Masterclass China Paediatric oesophageal foreign bodies 20 Beijing, China, 12-13th May 2018 Emily Lowe, Jessica Chapman, Ori Ron and Michael Stanton Biofilms in paediatric otorhinolaryngology 26 3rd ENT Masterclass® Europe S Goldie, H Ismail-Koch, P.G. Harries and R J Salib Berlin, Germany, 14-15th Sept 2018 Intracranial complications of ear, nose and throat infections in childhood 34 Alice Lording, Sanjay Patel and Andrea Whitney ® ENT Masterclass Switzerland The superior canal dehiscence syndrome 41 Lausanne, 5-6th Oct 2018 Simon Richard Mackenzie Freeman Tympanosclerosis 46 ® ENT Masterclass Sri Lanka Priya Achar and Harry Powell Colombo, 16-17th Nov 2018 Endoscopic ear surgery 49 Carolina Wuesthoff, Nicholas Jufas and Nirmal Patel o Limited places, on first come basis. Early applications advised. o Masterclass lectures, Panel discussions, Clinical Grand Rounds Vestibular function testing 57 o Oncology, Plastics, Pathology, Radiology, Audiology, Medico-legal Karen Lindley and Charlie Huins Auditory brainstem implantation 63 Website: www.entmasterclass.com Harry R F Powell and Shakeel S Saeed CYBER TEXTBOOK on operative surgery, Journal of ENT Masterclass®, Surgical management of temporal bone meningo-encephalocoele and CSF leaks 69 Application forms Mr. -
Surgical Management of Primary Palatoplasty - a Systematic Review
ISSN: 2455-2631 © April 2021 IJSDR | Volume 6, Issue 4 Surgical management of primary palatoplasty - A systematic Review Type of Manuscript: Review Study Running Title: Surgical management of primary palatoplasty MONISHA K Undergraduate student Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences.(SIMATS) Saveetha University, Chennai, India CORRESPONDING AUTHOR DR.SENTHIL MURUGAN.P Reader Department of Oral surgery Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS) Saveetha University, Tamilnadu, India Abstract: Clefts of the secondary palate, either isolated or accompanying, a cleft lip, are characterized by a defect in the palate of varying extent and by abnormal insertion of the levator veli palatini muscles. It is argued that repair of the palate should be carried out in one stage, shortly before or after 1 year of age, and should include intralveloplasty. Surgical corrections of cleft lip and palate primary lip repair such as (surgery for lip correction) and primary palatoplasty (reconstruction of hard and/or soft palate), are recommended in the first year of life. Primary palate surgery can be performed through various surgical techniques, of which the best for the type and the extent of the cleft is chosen, always seeking correction from the anatomic and functional point of view. Surgical failure may occur due to the surgical technique, the surgeon's skill, and/or the extent of the cleft palate. A Cleft palate repair is of concern to plastic surgeons, speech pathologists, otolaryngologists and orthodontists with respect to the timing of the operation, the type of palatoplasty to be considered and the effect of the repair on speech, facial growth and eustachian tube function. -
ANMC Specialty Clinic Services
Cardiology Dermatology Diabetes Endocrinology Ear, Nose and Throat (ENT) Gastroenterology General Medicine General Surgery HIV/Early Intervention Services Infectious Disease Liver Clinic Neurology Neurosurgery/Comprehensive Pain Management Oncology Ophthalmology Orthopedics Orthopedics – Back and Spine Podiatry Pulmonology Rheumatology Urology Cardiology • Cardiology • Adult transthoracic echocardiography • Ambulatory electrocardiology monitor interpretation • Cardioversion, electrical, elective • Central line placement and venous angiography • ECG interpretation, including signal average ECG • Infusion and management of Gp IIb/IIIa agents and thrombolytic agents and antithrombotic agents • Insertion and management of central venous catheters, pulmonary artery catheters, and arterial lines • Insertion and management of automatic implantable cardiac defibrillators • Insertion of permanent pacemaker, including single/dual chamber and biventricular • Interpretation of results of noninvasive testing relevant to arrhythmia diagnoses and treatment • Hemodynamic monitoring with balloon flotation devices • Non-invasive hemodynamic monitoring • Perform history and physical exam • Pericardiocentesis • Placement of temporary transvenous pacemaker • Pacemaker programming/reprogramming and interrogation • Stress echocardiography (exercise and pharmacologic stress) • Tilt table testing • Transcutaneous external pacemaker placement • Transthoracic 2D echocardiography, Doppler, and color flow Dermatology • Chemical face peels • Cryosurgery • Diagnosis -
Colposcopy.Pdf
CCololppooscoscoppyy ► Chris DeSimone, M.D. ► Gynecologic Oncology ► Images from Colposcopy Cervical Pathology, 3rd Ed., 1998 HistoHistorryy ► ColColpposcopyoscopy wwasas ppiioneeredoneered inin GGeermrmaanyny bbyy DrDr.. HinselmannHinselmann dduriurinngg tthhee 19201920’s’s ► HeHe sousougghtht ttoo prprooveve ththaatt micmicrroscopicoscopic eexaminxaminaationtion ofof thethe cervixcervix wouwoulldd detectdetect cervicalcervical ccancanceerr eeararlliierer tthhaann 44 ccmm ► HisHis workwork identidentiifiefiedd severalseveral atatyypicalpical appeappeararanancceses whwhicichh araree stistillll usedused ttooddaay:y: . Luekoplakia . Punctation . Felderung (mosaicism) Colposcopy Cervical Pathology 3rd Ed. 1998 HistoHistorryy ► ThrThrooughugh thethe 3030’s’s aanndd 4040’s’s brbreaeaktkthrhrouougghshs wwereere mamaddee regregaarrddinging whwhicichh aapppepeararancanceess wweerere moremore liklikelelyy toto prprogogressress toto invinvaasivesive ccaarcinomrcinomaa;; HHOOWEWEVVERER,, ► TheThessee ffiinndingsdings wweerere didifffficiculultt toto inteinterrpretpret sincesince theythey werweree notnot corcorrrelatedelated wwithith histologhistologyy ► OneOne resreseaearcrchherer wwouldould claclaiimm hhiiss ppatatientsients wwithith XX ffindindiingsngs nevernever hahadd ccaarcinomarcinoma whwhililee aannothotheerr emphemphaatiticcallyally belibelieevedved itit diddid ► WorldWorld wiwidede colposcopycolposcopy waswas uunnderderuutitillizizeedd asas aa diadiaggnosticnostic tooltool sseeconcondadaryry ttoo tthheseese discrepadiscrepannciescies HistoHistorryy -
Estimation of a Lower Bound for the Cumulative Incidence of Failure Of
CHAPTER 1 Introduction 11 1.1 Background The incidence of failure of a method for contraception is generally a matter of great interest to any person who uses, or whose sexual partner uses, that method. Not surprisingly, there is a large volume of research into the failure rates of all of the temporary methods for human contraception. However, there is a much more modest literature on the cumulative incidence of failure and annual failure rates of permanent sterilisation, particularly failures of female tubal sterilisation - often called “tubal ligation”, but including any means for occluding or interrupting the Fallopian tubes by surgical means. This is somewhat surprising given that female tubal sterilisation remains one of the most popular and widely used means of contraception. The Australian Study of Health and Relationships, which was conducted between May 2001 and June 2002 using a representative sample of 9,134 women aged 16 to 59 years, found that of the two-thirds of respondents who reported using some form of contraception, 22.5 per cent relied on tubal ligation or hysterectomy (these were not further distinguished), which was second in popularity only to oral contraceptives.1 The proportion of women in the 40-49 year age group who relied on tubal ligation or hysterectomy was 33 per cent, which was second in popularity only to vasectomy in the partner (34.6 per cent). In the 1995 United States Survey of Family Growth, conducted by the US National Center for Health Statistics, surgical sterilisation was the method of choice in